Endodermal Sinus Tumor clinical trials
The registry lists 25 studies for Endodermal Sinus Tumor across more than 10 countries. 8 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-25.
Status
- Completed
- 13
- Recruiting
- 7
- Active, not recruiting
- 3
- Not yet recruiting
- 1
- Terminated
- 1
Phase
- Phase 1
- 13
- Phase 2
- 5
- Phase 3
- 4
Where
- United States
- 21
- Canada
- 6
- Australia
- 4
- Puerto Rico
- 3
- United Kingdom
- 2
- New Zealand
- 2
Who runs them
National Cancer Institute (NCI) (7) · Children's Oncology Group (5) · Baylor College of Medicine (4) · Seattle Children's Hospital (2) · Shandong First Medical University (2) · N.N. Petrov National Medical Research Center of Oncology (1) · Alliance for Clinical Trials in Oncology (1) · Instituto do Cancer do Estado de São Paulo (1)
Studies
Recruiting first, then most recently updated. Showing 25 of 25 — search for more.
- Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsRecruitingNCT03067181Phase 39 countries
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsRecruitingNCT04715191Phase 11 country
- Agnostic Therapy in Rare Solid TumorsRecruitingNCT06638931Phase 21 country
- Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T CellsRecruitingNCT07148050Phase 11 country
- Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid TumorsNot yet recruitingNCT07224568Phase 11 country
- Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T CellsRecruitingNCT06198296Phase 11 country
- Molecular Epidemiology of Pediatric Germ Cell TumorsRecruitingNCT055640261 country
- High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell TumorsRecruitingNCT06418789Phase 21 country
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell TumorsActive, not recruitingNCT02375204Phase 312 countries
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid TumorsActive, not recruitingNCT05103631Phase 11 country
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid TumorsActive, not recruitingNCT04377932Phase 11 country
- Clinical Study of Chemotherapy in the Treatment of Recurrent/Refractory Yolk Sac Tumor in ChildrenCompletedNCT06341998Phase 2/31 country
- Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac TumorCompletedNCT06470464Phase 21 country
- Role of Axumin PET Scan in Germ Cell TumorCompletedNCT034268651 country
- Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell TumorsCompletedNCT00053352Phase 36 countries
- DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or SiblingsCompletedNCT014343551 country
- Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell TumorsCompletedNCT00467051Phase 24 countries
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving ChemotherapyCompletedNCT010805211 country
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 12 countries
- Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 12 countries
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to TreatmentCompletedNCT00929903Phase 11 country
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 11 country
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 12 countries
- Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 11 country
- Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerCompletedNCT00060372Phase 11 country